Clinical Trials Browser

Phase 2 × Breast Adenocarcinoma × Breast × Clear all

NCT06671262 2025-02-11

NEOTRIO-HR

Phase 2 Recruiting

Breast Adenocarcinoma

NCT02282345 2022-07-06

Talazoparib Before Standard Therapy in Treating Patients With Invasive, BRCA-Mutated Breast Cancer

Phase 2 Completed

36 enrolled 14 charts

Breast Adenocarcinoma